Inflammatory bowel diseases

(ISSN: 1078-0998, 1536-4844)

Table of Contents

From Inflammatory bowel diseases

2019 -

  • Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease. 
  • Treatment of Rituximab-induced Crohn's Disease With Ustekinumab Induction and Long-term Maintenance of Remission. 
  • Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease. 
  • Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN. 
  • Fighting the Hype for Predictors of Efficacy in Inflammatory Bowel Disease. 
  • Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015. 
  • No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps. 
  • Mobile Health in IBD: Enhancing Care, One Phone at a Time. 
  • Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease. 
  • Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease. 
  • Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease. 
  • Dining With Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD. 
  • Safety of Biologic Therapy in Liver Transplant Recipients: Case Closed? 
  • Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease. 
  • Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center. 
  • A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease Patients. 
  • Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease. 
  • Improving Quality of Care in Inflammatory Bowel Disease Through Patients' Eyes: IQCARO Project. 
  • Therapeutic Drug Monitoring Increases Drug Retention of Anti-Tumor Necrosis Factor Alpha Agents in Pediatric Patients With Crohn's Disease. 
  • Recurrence of Crohn's Disease After Small Bowel Transplantation: Fact or Fiction. 
  • All-trans Retinoic Acid Counteracts Diarrhea and Inhibition of Downregulated in Adenoma Expression in Gut Inflammation. 
  • Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis. 
  • Excisional Hemorrhoidectomy: Safe in Patients With Crohn's Disease? 
  • Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases. 
  • Injury Characteristics and Outcomes of Patients With Inflammatory Bowel Disease After Trauma: A Propensity Score Matched Analysis. 
  • Anastomotic Ulcers After Ileocolic Resection for Crohn's Disease Are Common and Predict Recurrence. 
  • Characterizing Clinical Features and Creating a Gene Expression Profile Associated With Pain Burden in Children With Inflammatory Bowel Disease. 
  • Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience. 
  • Is Ulcerative Colitis Associated With Primary Sclerosing Cholangitis an Undertreated Condition? 
  • Bariatric Surgery and Its Complications in Inflammatory Bowel Disease Patients. 
  • Inflammatory Bowel Disease and the Risk of Erectile Dysfunction. 
  • Reply to Letter to the Editor of Dr. Lai and Colleagues. 
  • Prolyl Hydroxylase Inhibition Mitigates Pouchitis. 
  • Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews. 
  • Cancer Risk in Inflammatory Bowel Disease. 
  • Matrix-Delivered Autologous Mesenchymal Stem Cell Therapy for Refractory Rectovaginal Crohn's Fistulas. 
  • Histopathological Mimics of Inflammatory Bowel Disease. 
  • Parental Education May Differentially Impact Pediatric Inflammatory Bowel Disease Phenotype Risk. 
  • Re: Parental Education May Differentially Modulate Pediatric Inflammatory Bowel Disease Phenotype Risk. 
  • Inflammation of the Ileal Anal Pouch: Do Biologics Really Change the Trajectory? 
  • Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring. 
  • Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients. 
  • Inactive Rhomboid Protein 2 Mediates Intestinal Inflammation by Releasing Tumor Necrosis Factor-α. 
  • Reply to Letter to the Editor of Dr. Sitkin et al., Regarding "Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome is Another Key to the Pathogenesis of Inflammatory Bowel Disease". 
  • Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease. 
  • Incidence, Duration, and Management of Anemia: A Nationwide Comparison Between IBD and Non-IBD Populations. 
  • Alternative and Complementary Approaches for the Treatment of Inflammatory Bowel Disease: Evidence From Cochrane Reviews. 
  • Cerebral Vasculitis in Crohn's Disease: Always a Complication of Inflammatory Bowel Disease or Tumor Necrosis Factor-Alpha Inhibition? 
  • The Unique Disease Course of Children with Very Early onset-Inflammatory Bowel Disease. 
  • Nanotechnology in the Treatment of Inflammatory Bowel Disease. 
  • Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States. 
  • Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease. 
  • Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases. 
  • Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype. 
  • Utilization of Diagnostic Imaging and Ionization Radiation Exposure Among an Inflammatory Bowel Disease Inception Cohort. 
  • Utilization of Diagnostic Imaging and Ionizing Radiation Exposure-Has the Tide Already Turned? 
  • Total CD3 T Cells Are Necessary and Sufficient to Induce Colitis in Immunodeficient Mice With Dendritic Cell-Specific Deletion of TGFbR2: A Novel IBD Model to Study CD4 and CD8 T-Cell Interaction. 
  • Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors. 
  • Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease. 
  • The Cost-effectiveness of Initial Immunomodulators or Infliximab Using Modern Optimization Strategies for Crohn's Disease in the Biosimilar Era. 
  • Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing. 
  • Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy. 
  • Predictors of Perianal Fistula Relapse in Crohn's Disease. 
  • Pedictors of Perianal Fistula Relapse in Crohn's Disease. 
  • Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease. 
  • Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry. 
  • How Do We Sequence Biologic Therapies in 2019? 
  • Assessing Small Bowel Stricturing and Morphology in Crohn's Disease Using Semi-automated Image Analysis. 
  • Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab. 
  • Making Qualitative Intestinal Stricture Quantitative: Embracing Radiomics in IBD. 
  • The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease. 
  • Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study. 
  • Is It Time For High Dose Influenza Vaccination In Inflammatory Bowel Diseases? 
  • Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial. 
  • Spotlight on Transition in Patients With Inflammatory Bowel Disease: A Systematic Review. 
  • Identification of Key Pro-Survival Proteins in Isolated Colonic Goblet Cells of Winnie, a Murine Model of Spontaneous Colitis. 
  • Comment on: "Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol". 
  • Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016. 
  • Health Care Cost for Children Newly Diagnosed With Inflammatory Bowel Disease. 
  • The Cost of Pediatric IBD Care: How to Best Invest in our Children. 
  • The Changing Epidemiology of Inflammatory Bowel Disease: What Goes Up May Come Down. 
  • Geographical Variation and Factors Associated With Inflammatory Bowel Disease in a Central Canadian Province. 
  • Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy. 
  • Increased Risk of Parkinson Disease in Inflammatory Bowel Disease Patients. 
  • Inflammatory Bowel Disease and Parkinson's Disease: A Reply to Letter to the Editor of Shih-Wei Lai. 
  • Evaluating Efficacy, Safety, and Pharmacokinetics After Switching From Infliximab Originator to Biosimilar CT-P13: Experience From a Large Tertiary Referral Center. 
  • Erratum to The Unsolved Link of Genetic Markers and Crohn's Disease Progression: A North American Cohort Experience. 
  • Diagnostic Approach to Monogenic Inflammatory Bowel Disease in Clinical Practice: A Ten-Year Multicentric Experience. 
  • A Population Pharmacokinetic and Exposure-Response Model of Golimumab for Targeting Endoscopic Remission in Patients With Ulcerative Colitis. 
  • IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas. 
  • Do Patients With Inflammatory Bowel Disease Benefit from an Enhanced Recovery Pathway? 
  • Portomesenteric Venous Thrombosis in Patients Undergoing Surgery for Medically Refractory Ulcerative Colitis. 
  • Should Surgical Inflammatory Bowel Disease Patients Be Given Extended Venous Thromboembolic Prophylaxis Postoperatively? 
  • Underutilization of Combination Anti-TNF Therapy in Population-based Study. 
  • A Population-Based Study of Combination vs Monotherapy of Anti-TNF in Persons With IBD. 
  • Corrigendum to Predicting Risk of Postoperative Disease Recurrence in Crohn's Disease: Patients With Indolent Crohn's Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery. 
  • Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study. 
  • Editorial: Risk of Cancer Development in IBD-Inflammation vs Immunosuppression. 
  • Anti-TNF Therapy Is Emerging as the Primary Treatment Modality in Pediatric Inflammatory Bowel Disease. 
  • Trends of Utilization of Tumor Necrosis Factor Antagonists in Children With Inflammatory Bowel Disease: A Canadian Population-Based Study. 
  • Corrigendum to A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD. 
  • A Comparative Case Study of the Impact of Psychotherapy on Inflammatory Bowel Disease Patients. 
  • Opportunistic Infections Are More Prevalent in Crohn's Disease and Ulcerative Colitis: A Large Population-Based Study. 
  • Opportunistic Infections and Opportunities for Action. 
  • Replacement Resistant Iron Deficiency Anemia in a Patient With Ulcerative Colitis in Remission: Investigating Beyond the Obvious. 
  • Corrigendum to Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study. 
  • Ustekinumab Improves Paradoxical Enteropathy Associated With Psoriasis Arthritis. 
  • Patients Perception of Risks and Benefits of Biologic Therapy. 
  • Letter to the Editor: Is There a Role for Switching Infliximab in Order to Regain Anti-TNF Response in Cases With Active Inflammatory Bowel Disease? 
  • Patients' Perceive Biologics to Be Riskier and More Dreadful Than Other IBD Medications. 
  • Corrigendum to Challenges in IBD Research: Environmental Triggers. 
  • Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer. 
  • Improved Population Pharmacokinetic Model for Predicting Optimized Infliximab Exposure in Pediatric Inflammatory Bowel Disease. 
  • Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn's Disease? 
  • Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. 
  • Environmental Microbial Factors Determine the Pattern of Inflammatory Lesions in a Murine Model of Crohn's Disease-Like Inflammation. 
  • Metastatic Crohn's Disease of the Aortic Valve Resulting in Severe Aortic Insufficiency, Non-infective Endocarditis, and Pericarditis. 
  • Gender Differences and Other Factors Associated with Weight Gain Following Initiation of Infliximab: A Post Hoc Analysis of Clinical Trials. 
  • Understanding the Cause of Weight Gain in Patients With IBD on Anti-TNF Medications. 
  • Is Antibiotic Use a Cause of IBD Worldwide? 
  • Antibiotic Use in Childhood and Adolescence and Risk of Inflammatory Bowel Disease: A Case-Control Study in the UK Clinical Practice Research Datalink. 
  • High Prevalence of Apical Periodontitis in Patients With Inflammatory Bowel Disease: An Age- and Gender- matched Case-control Study. 
  • Apical Periodontitis in Patients With Inflammatory Bowel Disease: A Puppet Master? 
  • Increased Incidence of Herpes Zoster Infection in Patients With Inflammatory Bowel Disease. 
  • Proactive Infliximab Drug Monitoring Is Superior to Conventional Management in Inflammatory Bowel Disease. 
  • TDM of Anti-TNF Agents: The Importance of Being Active! 
  • Pediatric Inflammatory Bowel Disease Complications Are More Likely on the Weekend. 
  • Weekend Surgical Admissions of Pediatric IBD Patients Have a Higher Risk of Complication in Hospitals Across the US. 
  • Dextran Sodium Sulfate-induced Colitis as a Model for Sarcopenia in Mice. 
  • The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease. 
  • Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease. 
  • Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review. 
  • Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort. 
  • Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: Is the Juice Worth the Squeeze? 
  • Integrative Analysis of Transcriptomic and Proteomic Profiling in Inflammatory Bowel Disease Colon Biopsies. 
  • Role of Lymphatic Deficiency in the Pathogenesis and Progression of Inflammatory Bowel Disease to Colorectal Cancer in an Experimental Mouse Model. 
  • Clinical Significance of Potassium Channel and NLRP3 Expression in Platelets of Active Ulcerative Colitis. 
  • The Impact of Spondyloarthritis and Joint Symptoms on Health-Related Quality of Life and Fatigue in IBD Patients. Results From a Population-Based Inception Cohort (20-Year Follow-up in the Ibsen Study). 
  • Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis. 
  • The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation. 
  • Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States. 
  • A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease. 
  • Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease. 
  • The Safety, Tolerability, and Pharmacokinetics Profile of BT-11, an Oral, Gut-Restricted Lanthionine Synthetase C-Like 2 Agonist Investigational New Drug for Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial. 
  • Persistent Salmonella enterica Serovar Typhimurium Infection Induces Protease Expression During Intestinal Fibrosis. 
  • A Manganese-Superoxide Dismutase From Thermus thermophilus HB27 Suppresses Inflammatory Responses and Alleviates Experimentally Induced Colitis. 
  • Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study. 
  • Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial. 
  • Capsule Retention in Crohn's Disease: A Meta-analysis. 
  • Hospitalization Outcomes for Inflammatory Bowel Disease in Teaching vs Nonteaching Hospitals. 
  • Imaging Features Associated With Failure of Nonoperative Management of Intraabdominal Abscesses in Crohn Disease. 
  • Increased Healthcare Utilization by Patients With Inflammatory Bowel Disease Covered by Medicaid at a Tertiary Care Center. 
  • Risk of Infection and Types of Infection Among Elderly Patients With Inflammatory Bowel Disease: A Retrospective Database Analysis. 
  • Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review. 
  • The Inflammatory Bowel Disease Medical Home: From Patients to Populations. 
  • The Role of Early Biologic Therapy in Inflammatory Bowel Disease. 
  • A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease Recurrence. 
  • Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection. 
  • Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study. 
  • Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers. 
  • The Relationship Between Adverse Childhood Experiences and Health Care Use in the Manitoba IBD Cohort Study. 
  • The Prevalence and Risk Factors of Undiagnosed Depression and Anxiety Disorders Among Patients With Inflammatory Bowel Disease. 
  • Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know. 
  • Management of Biological Therapy Before Elective Inflammatory Bowel Disease Surgeries. 
  • Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process. 
  • Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes. 
  • Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease. 
  • Health Care Indicators of Moderate to Severe IBD and Subsequent IBD-Related Disability: A Longitudinal Study. 
  • Vaccine-Preventable Diseases in Hospitalized Patients With Inflammatory Bowel Disease: A Nationwide Cohort Analysis. 
 
 

Journal Information